Importance of the S100B protein assessment in patients with isolated brain injury;Význam stanovení S100B proteinu u pacientů s izolovaným poraněním hlavy

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 70, Issue 5, 2007, Pages 521-526

  Lavička, Pavel ^a,e   Pikner, R ^b   Kormunda, S ^c   Topolcan O ^b   Bosman, R ^d   Chytra, I ^d   Holubec, L ^b   Choc, M ^a  

^a FN   (Czech Republic)

^b Odd lení Nukleární Medicíny Úsek Imunodiagnostiky   (Czech Republic)

^c UK   (Czech Republic)

^d Anesteziologicko resuscita ní Klinika FN   (Czech Republic)

^e NONE   (Czech Republic)

Author keywords

CT finding; Glasgow Coma Scale; Glasgow Outcome Scale; Isolated head injury; ISS; Resulting clinical status; S100B protein; TRISS

Indexed keywords

PROTEIN S100B;

ADULT; AGED; APACHE; ARTICLE; BRAIN INJURY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; CZECHOSLOVAKIA; FEMALE; GLASGOW COMA SCALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTION; PROTEIN FUNCTION; REFERENCE VALUE; SAMPLING; SCORING SYSTEM;

EID: 55049130850     PISSN: 12107859     EISSN: 18024041     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Heizmann CW, Fritz G, Schafer BW. S100 proteins: Structure, functions and pathology Front Biosci 2002; 7: d1356-1368.
2. Raabe A, Grolms C, Sorge O, Zimmermann M. Serum S-100B protein in Severe Head Injury. Neurosurgery 1999; 45: 477-483.
3. Rothoerl RD, Woertgen C, Holschuh M, Metz C, Brawanski A. S-100 Serum Levels after Minor and Major Head injury. J Trauma 1995;45: 765-767.
4. Woertgen C, Rothoerl RD, Brawanski A. Early S-100B serum level correlates to quality of life in patiens after severe head injury. Brain Injury 2002; 16: 807-816.
5. Biberthaler P, Mussack T, Wiedemann E, Kanz K-G, Koelch M, Gipper-Steppert C et al. Evaluation of S100b as a specific marker for neuronal damage due to minor head trauma. World J Surg 2001; 25: 93-7.
6. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Kellner J et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Injury 2000; 14: 1047-1055.
7. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995; 37: 417-429.
8. Cocchia D, Michetti F, Donato R. S100 antigen in normal human skin, Nature 1981; 294: 85-87.
9. Donato R. Perspectives in S100 protein biology. Cell Calcium 1991; 12: 713-26.
10. Kleindienst A, Ross Bulock M. A critical analysis of the role of the neurothropic protein S100B in acute brain injury. J Neurotrauma 2006; 23: 1185-2000.
11. Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis D et al. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem 2006; 13: 3719-3731.
12. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department:a role for protein S100B. J Neurol Neurosurg Psychiatry 2002; 73: 542-546.
13. Vos PE, Lamers Q Hendriks JC, van Haaren M, Beems T, Zimmermann C et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62: 1303-1310.
14. Raabe A, Kopetsch O, Woszczyk A, Lang J, Berlach R, Zimmermann M et al. S100B protein as a serum marker of secondary neurological complications in neurocritical care patiens. Neurol Res 2004; 26: 440-445.
15. Townend W, Dibble C, Abid K, Vail A, Sherwood R, Leckz F. Rapid elimination of protein S-100B from serum after minor head trauma. J Neurotrauma 2006; 23: 149-155.
16. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G et al. Protein S-100b serum levels in trauma-induced brain. Neurology 2003; 60: 947-951.